EMA Lapsed: Sitagliptin / Metformin hydrochloride Accord (metformin hydrochloride;sitagliptin hydrochloride monohydrate) — Accord Healthcare S.L.U.

View source ↗

Summary

The European Medicines Agency notes that Accord Healthcare's sitagliptin/metformin hydrochloride combination product has lapsed its marketing authorization for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin/metformin hydrochloride Accord (sitagliptin hydrochloride monohydrate; metformin hydrochloride)

Snippet

Status: Lapsed. Therapeutic area: Diabetes Mellitus, Type 2. MAH: Accord Healthcare S.L.U.. Decision date: 19/05/2025